Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Center of Excellence, |
RCV004813243 | SCV005438419 | likely pathogenic | Nephronophthisis 19 | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004748221 | SCV005347709 | uncertain significance | DCDC2-related disorder | 2024-08-15 | no assertion criteria provided | clinical testing | The DCDC2 c.558G>C variant is predicted to result in the amino acid substitution p.Arg186Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |